As of July/August 2023, 16 papers from Viruses (ISSN: 1999-4915) released in 2023 received enough citations to place them in the top 1% of the academic field of microbiology based on a highly cited threshold for the field and publication year.

The Viruses Editorial Office sincerely congratulates all the authors and hopes that they continue to have an academically productive relationship with the journal.

“Decreased Clinical Severity of Pediatric Acute COVID-19 and MIS-C and Increase of Incidental Cases during the Omicron Wave in Comparison to the Delta Wave”
by Patrick O. Kenney, Arthur J. Chang, Lorna Krabill and Mark D. Hicar
Viruses 2023, 15(1), 180; https://doi.org/10.3390/v15010180

“Molnupiravir and Nirmatrelvir/Ritonavir: Tolerability, Safety, and Adherence in a Retrospective Cohort Study”
by Maria Mazzitelli, Daniele Mengato, Lolita Sasset, Anna Ferrari, Samuele Gardin, Vincenzo Scaglione, Nicola Bonadiman, Lucrezia Calandrino, Silvia Cavinato, Sabrina Trivellato et al.
Viruses 2023, 15(2), 384; https://doi.org/10.3390/v15020384

“Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression”
by Andrea De Vito, Agnese Colpani, Laura Saderi, Mariangela Puci, Beatrice Zauli, Vito Fiore, Marco Fois, Maria Chiara Meloni, Alessandra Bitti, Cosimo Di Castri et al.
Viruses 2023, 15(1), 71; https://doi.org/10.3390/v15010071

“Tixagevimab/Cilgavimab in SARS-CoV-2 Prophylaxis and Therapy: A Comprehensive Review of Clinical Experience”
by Karolina Akinosoglou, Emmanouil-Angelos Rigopoulos, Georgia Kaiafa, Stylianos Daios, Eleni Karlafti, Eleftheria Ztriva, Georgios Polychronopoulos, Charalambos Gogos and Christos Savopoulos
Viruses 2023, 15(1), 118; https://doi.org/10.3390/v15010118

“TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection”
by Kristin Metzdorf, Henning Jacobsen, Marina C. Greweling-Pils, Markus Hoffmann, Tatjana Lüddecke, Felicitas Miller, Lars Melcher, Amy M. Kempf, Inga Nehlmeier, Dunja Bruder et al.
Viruses 2023, 15(2), 271; https://doi.org/10.3390/v15020271

“Cardiac Arrhythmias in Post-COVID Syndrome: Prevalence, Pathology, Diagnosis, and Treatment”
by Aydin Huseynov, Ibrahim Akin, Daniel Duerschmied and Rüdiger E. Scharf
Viruses 2023, 15(2), 389; https://doi.org/10.3390/v15020389

“Variability in the Clinical Course of COVID-19 in a Retrospective Analysis of a Large Real-World Database”
by Robert Flisiak, Piotr Rzymski, Dorota Zarębska-Michaluk, Przemysław Ciechanowski, Krystyna Dobrowolska, Magdalena Rogalska, Jerzy Jaroszewicz, Anna Szymanek-Pasternak, Marta Rorat, Dorota Kozielewicz et al.
Viruses 2023, 15(1), 149; https://doi.org/10.3390/v15010149

“Omicron Waves in Argentina: Dynamics of SARS-CoV-2 Lineages BA.1, BA.2 and the Emerging BA.2.12.1 and BA.4/BA.5”
by Carolina Torres, Mercedes Nabaes Jodar, Dolores Acuña, Romina Micaela Zambrana Montaño, Andrés Carlos Alberto Culasso, Ariel Fernando Amadio, Paula Aulicino, Santiago Ceballos, Marco Cacciabue, Humberto Debat et al.
Viruses 2023, 15(2), 312; https://doi.org/10.3390/v15020312

“Hyperinflammatory Response in COVID-19: A Systematic Review”
by Marcos Jessé Abrahão Silva, Layana Rufino Ribeiro, Maria Isabel Montoril Gouveia, Beatriz dos Reis Marcelino, Carolynne Silva dos Santos, Karla Valéria Batista Lima and Luana Nepomuceno Gondim Costa Lima
Viruses 2023, 15(2), 553; https://doi.org/10.3390/v15020553

“The Role of Viral Infections in the Onset of Autoimmune Diseases”
by Bhargavi Sundaresan, Fatemeh Shirafkan, Kevin Ripperger and Kristin Rattay
Viruses 2023, 15(3), 782; https://doi.org/10.3390/v15030782

“Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID”
by Aristo Vojdani, Elroy Vojdani, Evan Saidara and Michael Maes
Viruses 2023, 15(2), 400; https://doi.org/10.3390/v15020400

“A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies”
by Srijan Chatterjee, Manojit Bhattacharya, Sagnik Nag, Kuldeep Dhama and Chiranjib Chakraborty
Viruses 2023, 15(1), 167; https://doi.org/10.3390/v15010167

“Epizootic Haemorrhagic Disease Virus Serotype 8 in Tunisia, 2021”
by Soufien Sghaier, Corinne Sailleau, Maurilia Marcacci, Sarah Thabet, Valentina Curini, Thameur Ben Hassine, Liana Teodori, Ottavio Portanti, Salah Hammami, Lucija Jurisic et al.
Viruses 2023, 15(1), 16; https://doi.org/10.3390/v15010016

“Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors”
by Levente Zsichla and Viktor Müller
Viruses 2023, 15(1), 175; https://doi.org/10.3390/v15010175

“Pediatric Systemic Lupus Erythematous in COVID-19 Era”
by Ancuta Lupu, Ingrith Crenguta Miron, Cristina Gavrilovici, Anca Adam Raileanu, Iuliana Magdalena Starcea, Ileana Ioniuc, Alice Azoicai, Adriana Mocanu, Lacramioara Ionela Butnariu, Felicia Dragan et al.
Viruses 2023, 15(2), 272; https://doi.org/10.3390/v15020272

“Fragment-Based Approaches Identified Tecovirimat-Competitive Novel Drug Candidate for Targeting the F13 Protein of the Monkeypox Virus”
by Yasir Ali, Hina Imtiaz, Muhammad Mutaal Tahir, Fouzia Gul, Umair Ali Khan Saddozai, Ashfaq ur Rehman, Zhi-Guang Ren, Saadullah Khattak and Xin-Ying Ji
Viruses 2023, 15(2), 570; https://doi.org/10.3390/v15020570